Skip to content

Revised Biosynthetic Pathway of Alnumycin Involves a Complex Interplay of Redox Reactions, Stereoisomerization, and an Atypical DUF6081 Isomerase

Nov 2026 · Journal of the American Chemical Society · 0 citations · 28 references

Abstract

Alnumycin A is an antimicrobial natural product distinguished by an unusual 1,3-dioxane moiety attached to an aromatic polyketide core. While previous studies had established that d-ribose serves as the precursor to the 1,3-dioxane and its attachment to the aromatic ring system is catalyzed by a C-glycoside synthase, less is known about its subsequent transformation. Aln6 is a member of the domain of unknown function (DUF) 6081 protein family and was previously annotated as a cofactor-free oxidase. Herein, Aln6 is shown to catalyze a redox-neutral isomerization that converts the ribose moiety to a fused furan-dioxolane via an unprecedented rearrangement mechanism. Aln4 subsequently catalyzes an NADPH-dependent reductive ring-opening of the furan, setting the stage for nonenzymatic rearrangement of the dioxolane that produces the 1,3-dioxane structure and explains the stereochemical diversity of alnumycin A observed in vivo. Together, these findings not only revise the established view of the late-stage biosynthesis of alnumycin A but also redefine the chemistry of Aln6, expanding the catalytic repertoire of the DUF6081 family beyond canonical oxidative reactions.

View source

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.